Top Markets
#1 bitcastle Token bitcastle Token +152.04%
#2 MarsCoin MarsCoin +66.30%
#3 Palladium Network Palladium Network +53.32%
#4 Siren Siren +28.84%
#5 Bedrock Bedrock +22.61%
#6 edgeX edgeX +20.39%
#7 Useless Coin Useless Coin +19.40%
#8 Status Status +16.97%
#9 Asteroid Shiba Asteroid Shiba +16.77%
#10 PondCoin PondCoin +15.92%
Coin of the day
bitcastle Token bitcastle Token
Setări
Limbă
ROMâNă
Monedă
USD
Temă
KemPharm, Inc. KemPharm, Inc.

KemPharm, Inc.

KMPH
Rang în acțiuni #18401
KemPharm, Inc. operates as a specialized pharmaceutical firm focused on... KemPharm, Inc. operates as a specialized pharmaceutical firm focused on discovering and advancing proprietary prodrugs to tackle serious medical conditions across the United States. The company employs its innovative Ligand Activated Therapy (LAT) platform to create improved prodrug versions of medications already approved by the FDA, and also to develop prodrugs from existing compounds for potential applications in new disease indications. Its pipeline of investigational prodrugs strategically targets high-need areas such as attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) disorders, including idiopathic hypersomnia (IH). KP1077, KemPharm's leading experimental compound, is a prodrug of d-methylphenidate, known as serdexmethylphnidate, and is currently in Phase II clinical trials for the treatment of IH and narcolepsy. Additionally, the company is advancing KP879, a prodrug candidate designed to treat stimulant use disorder, which is undergoing Phase I clinical evaluation. KemPharm has also obtained FDA approval for AZSTARYS, a new once-daily ADHD treatment for patients aged six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company holds collaboration and license agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Founded in 2006, KemPharm, Inc. is headquartered in Celebration, Florida.
Preț acțiune
$5.81
Ultima sincronizare: 2023-02-28
Capitalizare de piață
$200.14M
Schimbare (1 zi)
-0.34%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează KemPharm, Inc. (KMPH)

Categorie

Healthcare
EPS pentru KemPharm, Inc. (KMPH)
EPS la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor KemPharm, Inc., EPS-ul actual al companiei (TTM) este 0. La sfârșitul anului 2026, compania avea un EPS de 0 egal cu EPS-ului din 2026, care a fost de 0.
Istoricul EPS pentru KemPharm, Inc. din 2026 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
Nu sunt suficiente date pentru perioada selectată.
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH